Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-906-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute oral median lethal dose (LD50 cut- off value) the test substance in Wistar rats was found to be 5000 mg/kg body weight.
Based on the results of this study, an indication of the classification for the test substance is ; Category 5 or Unclassified, based on Globally Harmonized System of Classification and Labelling of Chemicals (GHS 2017)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Study Initiation date: September 11, 2017 and Study Completion date: November 10, 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Species : Rat (Rattus norvegicus)
Strain : RccHan : WIST
Age/Weight at Dosing : 9 to 11 weeks, Weight (g) Minimum: 174.0, Maximum: 201.8
Source : Animal Breeding Facility, Jai Research Foundation
Total Number of Animals Used : Twelve females Female rats were nulliparous and non-pregnant
Acclimatisation Period : 6 to 11 days
Husbandry Practices
Caging : Polypropylene rat cages covered with stainless steel grid top were used.Autoclaved clean rice husk was used as the bedding material. Wooden chew blocks were provided as enrichment material.
Water Bottle : Each cage was supplied with a polypropylene water bottle with a stainless steel nozzle.
Housing : Three rat per cage
Room Sanitation : Daily: 1. Rack was cleaned with cloth, 2. Floor of experimental procedure room was swept, 3. All work tops and the floor were mopped with a disinfectant solution
Feed : Teklad Certified Global High Fiber Rat/Mice Feed manufactured by Envigo, USA.
Water : UV sterilized water filtered through Reverse Osmosis water filtration system.
Animal Room : BMR 29, Department of Toxicology
Temperature : 20 to 23°C
Relative Humidity : 49 to 67%
Air Changes : Minimum 15 air changes/hour
Photoperiod : The photoperiod was 12 hours artificial light and 12 hours darkness, light hours being 06:00 h – 18:00 h (photoperiod was maintained through automatic timer) - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- The test item was found to be insoluble in RO water and 0.5% CMC while formed homogenous suspension in corn oil, so the actual dose formulation was prepared using corn oil as vehicle.
Required quantity [300 mg (for set I and II) and 2000 mg (for set III and IV)] were mixed in corn oil and the final volume was made up 10 mL for set I, set II, set III and set IV with corn oil.
Gavage solutions were prepared freshly prior to dosing on all the occasions.
Individual dose volume was adjusted according to body weight and dose level. All rats were dosed by oral gavage (day 0) using a BD 1 mL disposable syringe. Rats were fasted overnight prior to dosing and until three hours post-dosing. - Doses:
- The first set (set I) of three female rats was given a single dose of 300 mg teast substance/ kg body weight. No mortality was observed
Second set (set II) of three female rats was administered with same dose level of 300 mg teast substance/ kg body weight. No mortality was observed
Third set (set III) of three female rats was administered with higher dose level of 2000 mg teast substance/ kg body weight. No mortality was observed
Fourth set (set IV) of three female rats was administered with same dose level of 2000 mg teast substance/ kg body weight. No mortality was observed - No. of animals per sex per dose:
- Three
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Observed twice a day for morbidity and mortality for a period of 14 days following oral dosing.
Clinical signs were recorded once a day.
Individual body weight was recorded prior to dosing on day 0 and on days 7 and 14.
- Necropsy of survivors performed: yes
- Other examinations performed: End of the 14 days observation period, all the rats were euthanised by carbon dioxide asphyxiation and were subjected to gross pathological examination, consisting of external examination and opening of the abdominal and thoracic cavities. - Preliminary study:
- The first set (set I) of three female rats was given a single dose of 300 mg test substance/kg body weight. No mortality was observed at this dose level so a second set (set II) of three female rats was administered with same dose level of 300 mg test substance /kg body weight. No mortality was observed at this dose level so a third set (set III) of three female rats was administered with higher dose level of 2000 mg test substance /kg body weight. No mortality was observed at this dose level so a fourth set (set IV) of three female rats was administered with same dose level of 2000 mg test substance /kg body weight. No mortality was observed at this dose level hence the endpoint was achieved and further testing was not required.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- No mortality was observed in rats treated with 300 and 2000 mg the test substance/kg body weight.
- Clinical signs:
- other: No adverse clinical sign was observed in all the rats treated with 300 and 2000 mg the test substance/kg body weight.
- Gross pathology:
- External: No abnormality detected
Internal: No abnormality detected - Other findings:
- - Organ weights:
- Histopathology: No abnormality detected
- Potential target organs: No abnormality detected
- Other observations: No abnormality detected - Interpretation of results:
- other: Category 5 or Unclassified
- Conclusions:
- No mortality was observed in rats treated with 300 and 2000 mg test substance/kg body weight. The acute oral LD50 (cut-off value) of the test substance in Wistar rats was found to be 5000 mg/kg body weight.
The acute oral median lethal dose (LD50 cut- off value) the test substance in Wistar rats was found to be 5000 mg/kg body weight.
Based on the results of this study, an indication of the classification for the test substance is ; Category 5 or Unclassified, based on Globally Harmonized System of Classification and Labelling of Chemicals (GHS 2017) - Executive summary:
In an acute oral toxicity study, four sets of fasted Wistar rats (3 females/set) (9 to 11 weeks) were given a single oral dose ofthe test substanceat 300 (for set Iand II) and 2000 (for set III and IV) mg/kg body weight and all rats were observed for 14 days. There were no treatment-related mortality, clinical sign and changes in body weight or necropsy findings observed. The acute oral median lethal dose (LD50 cut-off value) of the test substance in Wistar rats was found to be 5000 mg/kg body weight. Based on the results of this study, an indication of the classification forthe test substanceis as follows:
Globally Harmonized System of Classification and Labelling of Chemicals (GHS 2017) : Category 5 or Unclassified
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- The study was conducted with OECD guidelines by GLP Certified lab.
Additional information
Justification for classification or non-classification
The acute oral median lethal dose (LD50 cut- off value) the test substance in Wistar rats was found to be 5000 mg/kg body weight.
Based on the results of this study, an indication of the classification for the test substance is ; Category 5 or Unclassified, based on Globally Harmonized System of Classification and Labelling of Chemicals (GHS 2017)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.